annual CFI:
-$63.00M+$6.19M(+8.95%)Summary
- As of today (May 29, 2025), AMRX annual cash flow from investing activities is -$63.00 million, with the most recent change of +$6.19 million (+8.95%) on December 31, 2024.
- During the last 3 years, AMRX annual CFI has risen by +$131.19 million (+67.56%).
- AMRX annual CFI is now -221.74% below its all-time high of -$19.58 million, reached on December 31, 2019.
Performance
AMRX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$17.80M-$1.74M(-10.83%)Summary
- As of today (May 29, 2025), AMRX quarterly cash flow from investing activities is -$17.80 million, with the most recent change of -$1.74 million (-10.83%) on March 31, 2025.
- Over the past year, AMRX quarterly CFI has increased by +$1.96 million (+9.93%).
- AMRX quarterly CFI is now -159.36% below its all-time high of $29.98 million, reached on September 30, 2019.
Performance
AMRX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$61.03M+$1.96M(+3.11%)Summary
- As of today (May 29, 2025), AMRX TTM cash flow from investing activities is -$61.03 million, with the most recent change of +$1.96 million (+3.11%) on March 31, 2025.
- Over the past year, AMRX TTM CFI has increased by +$16.18 million (+20.95%).
- AMRX TTM CFI is now -543.00% below its all-time high of -$9.49 million, reached on September 30, 2019.
Performance
AMRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AMRX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.9% | +9.9% | +20.9% |
| 3 y3 years | +67.6% | +81.7% | +78.1% |
| 5 y5 years | -221.7% | +93.2% | +76.5% |
AMRX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +67.6% | -175.3% | +81.7% | -24.6% | +78.1% |
| 5 y | 5-year | -221.7% | +80.2% | -175.3% | +93.2% | -24.6% | +80.8% |
| alltime | all time | -221.7% | +84.1% | -159.4% | +94.8% | -543.0% | +84.8% |
AMRX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$17.80M(+10.8%) | -$61.03M(-3.1%) |
| Dec 2024 | -$63.00M(-9.0%) | -$16.06M(-22.5%) | -$63.00M(-19.9%) |
| Sep 2024 | - | -$20.71M(+220.4%) | -$78.63M(+10.1%) |
| Jun 2024 | - | -$6.46M(-67.3%) | -$71.39M(-7.5%) |
| Mar 2024 | - | -$19.76M(-37.6%) | -$77.21M(+11.6%) |
| Dec 2023 | -$69.19M(-60.3%) | -$31.69M(+135.2%) | -$69.19M(+41.3%) |
| Sep 2023 | - | -$13.48M(+9.7%) | -$48.96M(-42.3%) |
| Jun 2023 | - | -$12.28M(+4.7%) | -$84.82M(-4.3%) |
| Mar 2023 | - | -$11.74M(+2.4%) | -$88.65M(-49.1%) |
| Dec 2022 | -$174.31M(-10.2%) | -$11.47M(-76.8%) | -$174.31M(-30.2%) |
| Sep 2022 | - | -$49.33M(+206.1%) | -$249.81M(+17.8%) |
| Jun 2022 | - | -$16.12M(-83.5%) | -$212.11M(-23.9%) |
| Mar 2022 | - | -$97.39M(+12.0%) | -$278.88M(+43.6%) |
| Dec 2021 | -$194.18M | -$86.97M(+647.6%) | -$194.18M(+39.7%) |
| Sep 2021 | - | -$11.63M(-86.0%) | -$139.01M(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$82.89M(+553.0%) | -$142.16M(+108.5%) |
| Mar 2021 | - | -$12.69M(-60.1%) | -$68.20M(-78.5%) |
| Dec 2020 | -$317.55M(+1521.8%) | -$31.80M(+115.1%) | -$317.55M(+9.3%) |
| Sep 2020 | - | -$14.78M(+65.6%) | -$290.52M(+18.2%) |
| Jun 2020 | - | -$8.93M(-96.6%) | -$245.75M(-5.5%) |
| Mar 2020 | - | -$262.04M(+5397.0%) | -$260.16M(+1228.7%) |
| Dec 2019 | -$19.58M(-95.1%) | -$4.77M(-115.9%) | -$19.58M(+106.3%) |
| Sep 2019 | - | $29.98M(-228.5%) | -$9.49M(-88.2%) |
| Jun 2019 | - | -$23.33M(+8.7%) | -$80.25M(-79.9%) |
| Mar 2019 | - | -$21.47M(-503.4%) | -$398.35M(+0.5%) |
| Dec 2018 | -$396.38M(+302.2%) | $5.32M(-113.0%) | -$396.38M(-1.3%) |
| Sep 2018 | - | -$40.77M(-88.1%) | -$401.70M(+11.3%) |
| Jun 2018 | - | -$341.43M(+1651.0%) | -$360.92M(+1751.0%) |
| Mar 2018 | - | -$19.50M | -$19.50M |
| Dec 2017 | -$98.55M(-20.9%) | - | - |
| Dec 2016 | -$124.61M | - | - |
FAQ
- What is Amneal Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual CFI year-on-year change?
- What is Amneal Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly CFI year-on-year change?
- What is Amneal Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals TTM CFI year-on-year change?
What is Amneal Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of AMRX is -$63.00M
What is the all time high annual CFI for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual cash flow from investing activities is -$19.58M
What is Amneal Pharmaceuticals annual CFI year-on-year change?
Over the past year, AMRX annual cash flow from investing activities has changed by +$6.19M (+8.95%)
What is Amneal Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of AMRX is -$17.80M
What is the all time high quarterly CFI for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly cash flow from investing activities is $29.98M
What is Amneal Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, AMRX quarterly cash flow from investing activities has changed by +$1.96M (+9.93%)
What is Amneal Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of AMRX is -$61.03M
What is the all time high TTM CFI for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high TTM cash flow from investing activities is -$9.49M
What is Amneal Pharmaceuticals TTM CFI year-on-year change?
Over the past year, AMRX TTM cash flow from investing activities has changed by +$16.18M (+20.95%)